August 2, 2017
Bayer’s New Mesothelioma Treatment Proves Unsuccessful
Despite a promising start, Bayer’s most recent attempt at a new targeted treatment for mesothelioma has failed early stage testing. In July, the company announced that clinical trials for the much-anticipated drug Anetumab Ravtansine did not meet expectations. This is…
July 29, 2017
For Alleged Improper Asbestos Removal, a Business Owner is in Prison and Faces a Huge Fine
Asbestos is an extremely hazardous material, and businesses have strict regulations with regard to dealing with the disease-causing substance. Russell Stewart, former business owner of a demolition company in Cleveland, Ohio, has learned just how serious the U.S. government is…